Aktuellt
SENASTE
Redeye returns with a research update following the Q4 report and recent events in the company. We reiterate our base case and conclude that 2022 was a transformational year for the company, for both good and bad. We see good prospect for positive momentum in the share during 2023 if Saniona delivers on its agenda.
LÄS MER
